We are live on ! Find out more
CCS

Crosspoint Capital Strategies Portfolio holdings

AUM $50.4M
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+11.45%
1 Year Est. Return
-15.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$207M
AUM Growth
-$79.4M
Cap. Flow
-$91M
Cap. Flow %
-43.93%
Top 10 Hldgs %
21.97%
Holding
890
New
197
Increased
94
Reduced
202
Closed
375

Sector Composition

Rank Sector Weight
1 Healthcare 17.98%
2 Technology 16.3%
3 Consumer Discretionary 16.11%
4 Consumer Staples 11.7%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNGT
876
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
-161
Closed -$5K
HAWK
877
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
-65
Closed -$2K
MHR
878
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
-1,725
Closed -$5K
DO
879
DELISTED
Diamond Offshore Drilling
DO
-31
Closed -$1K
TIVO
880
DELISTED
TIVO INC
TIVO
-600
Closed -$7K
FRP
881
DELISTED
FAIRPOINT COMMUNICATIONS INC.
FRP
$0 ﹤0.01%
+16
New
DNY
882
DELISTED
DONNELLEY R R & SONS CO
DNY
-1,475
Closed -$25K
POM
883
DELISTED
PEPCO HOLDINGS, INC.
POM
-300
Closed -$8K

Similar funds

Crosspoint Capital Strategies's Q1 2015 Portfolio in Review

As of Q1 2015, Crosspoint Capital Strategies held 890 positions worth $207M, down 28% from $287M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Crosspoint Capital Strategies withdrew a net $91M in Q1 2015, closing 375 positions and reducing 202 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 12% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Crosspoint Capital Strategies opened a new position in Dorchester Minerals worth $4.64M.

  • Crosspoint Capital Strategies's largest Q1 2015 buy was Dorchester Minerals: 204,210 shares worth $4.64M.
  • Crosspoint Capital Strategies added most to Ambarella in Q1 2015, an estimated $3.51M increase.
  • Crosspoint Capital Strategies's biggest Q1 2015 reduction was Berkshire Hathaway Class B, cutting an estimated $7.89M.
  • Crosspoint Capital Strategies fully exited Agios Pharmaceuticals in Q1 2015, selling an estimated $4.46M.
  • Crosspoint Capital Strategies's ten largest holdings make up 22% of its $207M portfolio in Q1 2015.
  • Crosspoint Capital Strategies opened 197 new positions and closed 375 in Q1 2015.
  • Crosspoint Capital Strategies's portfolio value fell 28% quarter-over-quarter to $207M.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2015, filed 18 May 2015.